PRELUDE CAPITAL MANAGEMENT, LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 66 filers reported holding IMMUNE DESIGN CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$193,000
+109.8%
32,983
+62.5%
0.01%
+83.3%
Q2 2018$92,000
+384.2%
20,302
+968.5%
0.01%
+200.0%
Q2 2017$19,000
+375.0%
1,900
+216.7%
0.00%
Q1 2017$4,0000.0%600
-11.9%
0.00%
Q4 2016$4,000
-42.9%
681
-14.9%
0.00%
-100.0%
Q2 2016$7,0008000.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q3 2017
NameSharesValueWeighting ↓
Versant Venture Management, LLC 2,208,210$16,738,232,00018.66%
ProQuest Associates IV LLC 1,962,720$14,877,0004.10%
BVF INC/IL 1,200,000$9,096,0001.71%
Abingworth LLP 197,300$1,494,0001.43%
NEXTHERA CAPITAL LP 305,000$2,312,0001.42%
Cormorant Asset Management, LP 432,990$3,282,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 203,000$1,539,0000.25%
DAFNA Capital Management LLC 40,000$303,0000.21%
Monashee Investment Management LLC 50,000$379,0000.13%
Eventide Asset Management 180,000$1,364,0000.08%
View complete list of IMMUNE DESIGN CORP shareholders